RxDoctor Payments Data

Luke Thompson, PA

Physician Assistant · Asheville, NCNPI 1003114067

Payments from drug & device makers

$1,058in general payments, 2019–2025

Across 47 payments — averaging $22.51 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Ferring Pharmaceuticals Inc.$254
  • Biosense Webster, Inc.$163
  • Indivior Inc.$148
  • Pfizer$90
  • Otsuka America Pharmaceutical, Inc.$68
  • AstraZeneca$62
  • plus $272 from 10 others

What the payments were for

  • Food & beverage$1,058100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,058 in reported general payments places this provider in the 70th percentile of 7,441 physician assistant providers in North Carolina.

See all physician assistant providers in North Carolina

Medicare billing

Part B allowed, 2024
$201
Medicare patients
13
Services billed
23

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin47$44,439
FarxigaDapagliflozin Propanediol25$34,017
CreonLipase/Protease/Amylase12$33,770
OzempicSemaglutide29$31,771
EliquisApixaban28$29,763
JanuviaSitagliptin Phosphate40$29,264
XareltoRivaroxaban17$26,863
LinzessLinaclotide17$18,782
Tresiba Flextouch U-100Insulin Degludec16$7,749
EntrestoSacubitril/Valsartan12$7,746
Repatha SureclickEvolocumab13$6,814
Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl31$5,314
SymbicortBudesonide/Formoterol Fumarate17$5,038
Lantus SolostarInsulin Glargine,hum.Rec.Anlog33$3,749
NovologInsulin Aspart14$3,054

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance$15$44,43947 claims
AstraZenecaFarxiga, Symbicort$62$39,05542 claims
Novo NordiskOzempic, Novolog$49$34,82643 claims
PfizerEliquis$90$29,76328 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 7,441 physician assistant providers in North Carolina.

Other physician assistant in Asheville

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →